Disc Medicine, Inc.
IRON
$77.44
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 79.87M | 76.82M | 65.38M | 54.39M | 45.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 268.41M | 264.75M | 235.17M | 203.60M | 168.76M |
| Operating Income | -268.41M | -264.75M | -235.17M | -203.60M | -168.76M |
| Income Before Tax | -245.58M | -241.31M | -211.82M | -180.66M | -144.93M |
| Income Tax Expenses | 310.00K | 293.00K | 361.00K | 449.00K | 461.00K |
| Earnings from Continuing Operations | -245.89 | -241.60 | -212.18 | -181.11 | -145.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -245.89M | -241.60M | -212.18M | -181.11M | -145.39M |
| EBIT | -268.41M | -264.75M | -235.17M | -203.60M | -168.76M |
| EBITDA | -268.06M | -264.40M | -234.89M | -203.40M | -168.64M |
| EPS Basic | -6.57 | -6.61 | -5.98 | -5.35 | -4.47 |
| Normalized Basic EPS | -4.09 | -4.11 | -3.72 | -3.34 | -2.79 |
| EPS Diluted | -6.57 | -6.61 | -5.98 | -5.35 | -4.47 |
| Normalized Diluted EPS | -4.09 | -4.11 | -3.72 | -3.34 | -2.79 |
| Average Basic Shares Outstanding | 149.99M | 146.33M | 141.16M | 133.52M | 128.28M |
| Average Diluted Shares Outstanding | 149.99M | 146.33M | 141.16M | 133.52M | 128.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |